Loading…
Will artificial intelligence chatbots replace clinical pharmacologists? An exploratory study in clinical practice
Purpose Recently, there has been a growing interest in using ChatGPT for various applications in Medicine. We evaluated the interest of OpenAI chatbot (GPT 4.0) for drug information activities at Toulouse Pharmacovigilance Center. Methods Based on a series of 50 randomly selected questions sent to o...
Saved in:
Published in: | European journal of clinical pharmacology 2023-10, Vol.79 (10), p.1375-1384 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose
Recently, there has been a growing interest in using ChatGPT for various applications in Medicine. We evaluated the interest of OpenAI chatbot (GPT 4.0) for drug information activities at Toulouse Pharmacovigilance Center.
Methods
Based on a series of 50 randomly selected questions sent to our pharmacovigilance center by healthcare professionals or patients, we compared the level of responses from the chatbot GPT 4.0 with those provided by specialists in pharmacovigilance.
Results
Chatbot answers were globally not acceptable. Responses to inquiries regarding the assessment of drug causality were not consistently precise or clinically meaningful.
Conclusion
The interest of chatbot assistance needs to be confirmed or rejected through further studies conducted in other pharmacovigilance centers. |
---|---|
ISSN: | 0031-6970 1432-1041 1432-1041 |
DOI: | 10.1007/s00228-023-03547-8 |